Journal of Eating Disorders, published by BMC, is a leading Open Access journal dedicated to advancing knowledge and understanding of eating disorders. With an ISSN of 2050-2974, it has been a valuable resource for researchers and practitioners since its inception in 2013. This journal resides in the prestigious United Kingdom and provides a platform for high-quality research, encompassing areas such as behavioral neuroscience, nutrition and dietetics, as well as psychiatry and mental health. Notably, it achieved an impressive Q1 ranking in Nutrition and Dietetics and holds a Q2 classification in both Behavioral Neuroscience and Psychiatry and Mental Health for the year 2023. With a robust Scopus ranking, including a 67th percentile in Psychiatry and Mental Health, the journal is committed to facilitating vital discourse and disseminating groundbreaking findings that cater to both academic and clinical settings. The wide-reaching impact of the research published within its pages makes it an essential tool for professionals, students, and anyone with an interest in understanding and addressing eating disorders.

Journal of Psychiatric Practice, published by Lippincott Williams & Wilkins, is a premier journal dedicated to advancing the field of psychiatry and mental health. With a focus on evidence-based clinical practice, the journal has been a respected resource since its inception, providing a platform for a wide range of articles, including original research, reviews, and case reports from 1997 to the present. As of 2023, it holds a Q3 ranking in Psychiatry and Mental Health, reflecting its influential role in the academic community. The Journal is aimed at researchers, mental health professionals, and students, promoting the dissemination of essential knowledge and innovative practices. Subscribers benefit from the latest findings and discussions in the field while contributing to the ongoing advancements in psychiatric care. Although not classified as open access, the journal ensures wide accessibility to its valuable content, further solidifying its commitment to the mental health discipline.

Middle East Current Psychiatry (MECPsych), published by SpringerNature, is a prominent open-access journal dedicated to advancing the field of psychiatry and mental health in the Middle East and beyond. Since its establishment in 2011, MECPsych has aimed to disseminate high-quality research, reviews, and reports that capture recent developments in psychiatric science, clinical practice, and public health considerations in mental well-being. With an impact factor reflective of its growing influence and classified in the Q3 quartile for Psychiatry and Mental Health, the journal offers invaluable insights backed by rigorous peer review processes. Operating under an open access model since 2019, MECPsych ensures that its articles are freely accessible to a global readership, enhancing the visibility and application of research findings. As part of its ongoing commitment to enriching understanding in the field, MECPsych also encourages submissions that explore the unique cultural, societal, and economic factors influencing mental health across the region. This approach not only supports researchers, professionals, and students in their pursuit of knowledge but also fosters a collaborative dialogue among mental health stakeholders in the Middle East and around the world.

The Revista Mexicana de Neurociencia, published by the ACAD MEXICANA NEUROLOGIA, serves as a pivotal platform for the dissemination of research within the field of neurology and neuroscience. Although it was active from 2008 to 2014 and is no longer covered in Scopus, the journal still holds a significant place in the academic community, addressing critical topics relevant to both clinical and experimental neurology. With an emphasis on advancing knowledge in neuropsychology and public health, this journal targets researchers, professionals, and students alike, fostering an interdisciplinary dialogue that can enhance the understanding of neurological conditions within Mexico and beyond. As it stands, the journal is not open access, which may present challenges for accessibility, yet its affiliation with recognized academic standards underlines its commitment to quality research. This platform once provided insights that can inform practice and stimulate innovative approaches in the management of neurological disorders, underscoring its importance in the evolving landscape of neuroscience.

Neuropsychiatria i Neuropsychologia is a pivotal journal dedicated to the exploration of behavioral neuroscience, neuropsychology, and psychiatry, published by TERMEDIA PUBLISHING HOUSE LTD in Poland. This journal, with an ISSN of 1896-6764, has been a significant contribution to the scientific community since its inception in 2009 and continues to converge its findings until 2024. While it operates under a traditional access model, its commitment to disseminating research in these critical fields is unwavering. The journal currently holds a Q4 classification in multiple categories including Behavioral Neuroscience and Neuropsychology, reflecting its growing influence in the landscape of mental health studies. With Scopus rankings displaying a percentile standing in the bottom quartile, Neuropsychiatria i Neuropsychologia presents an opportunity for authors and researchers to contribute and engage with emerging findings in psychiatry and behavioral science. By fostering scholarly communication and collaboration, this journal serves as a valuable resource for researchers, professionals, and students seeking to advance their understanding and knowledge within these vital areas of study.

JPAD - Journal of Prevention of Alzheimer’s Disease, published by Springer Basel AG, is a premier academic journal dedicated to advancing research in the critical field of Alzheimer’s disease prevention. Its impactful contributions to the fields of neurology, psychiatry, and mental health have led it to achieve a Q1 ranking in multiple categories, including neurology (clinical) and psychiatry and mental health. Since its inception in 2017, JPAD has become an essential platform for researchers and professionals aiming to stay at the forefront of developments in Alzheimer’s disease research, prevention strategies, and innovative therapies. The journal provides a valuable open access option for disseminating high-quality research to a global audience, enhancing its visibility and impact. With its strategic focus and rigorous peer-review process, JPAD is committed to fostering collaboration and knowledge exchange among scientists, clinicians, and practitioners, ultimately contributing to the global effort to combat Alzheimer's disease.

European Archives of Psychiatry and Clinical Neuroscience is a prominent peer-reviewed journal published by Springer Heidelberg, focusing on the interdisciplinary aspects of psychiatry and clinical neuroscience. With an ISSN of 0940-1334 and an E-ISSN of 1433-8491, this journal provides a rigorous platform for innovative research spanning biological psychiatry, pharmacology, and various aspects of mental health. The journal boasts a distinguished impact factor that places it in the Q2 category for Biological Psychiatry and Q1 in both Medicine (miscellaneous) and Psychiatry and Mental Health as of 2023, reflecting its significant contribution to the field. Additionally, its Scopus rankings highlight its esteemed position among the top journals, particularly in Medicine and Neuroscience disciplines. Readers can access a wealth of valuable research articles, case studies, and reviews, crucial for advancing understanding and treatment within these vital fields. Initially converged in 1990, the journal continues to evolve and support scholarly dialogue until 2024 and beyond, making it an essential resource for researchers, clinicians, and students alike.

Neuropsychopharmacology Reports is a leading open-access journal published by WILEY, dedicated to advancing the fields of clinical psychology, pharmacology, psychiatry, and mental health. Established in 2018, the journal aims to disseminate high-quality research findings, critical reviews, and innovative methodologies that elucidate the complexities of neuropsychopharmacology in enhancing mental health outcomes. With an impressive impact indicated by its Q2 rankings in several categories including Clinical Psychology and Pharmacology (medical) as of 2023, Neuropsychopharmacology Reports stands out as a vital resource for researchers, professionals, and students keen on exploring the interplay between pharmacological interventions and psychological well-being. The journal’s open-access nature ensures that critical advancements in this rapidly evolving field are readily available to a global audience, fostering collaboration and discourse among scholars and practitioners alike. Building on its indexed status with Scopus, the journal is positioned as a noteworthy contributor to ongoing discussions and developments in psychiatry and medical pharmacology.

The Brazilian Journal of Psychiatry is a prominent peer-reviewed journal dedicated to advancing the field of psychiatry and mental health, published by the Associação Brasileira de Psiquiatria. With an impressive Q2 ranking in the Psychiatry and Mental Health category for 2023 and a Scopus rank of #130 out of 567, this journal serves as a vital resource for researchers, clinicians, and students alike. Since its transition to Open Access in 1999, it has aimed to disseminate high-quality research, innovative practices, and critical insights relevant to mental health in Brazil and beyond. The journal's focus spans various topics in psychiatry, aiming to bridge the gap between research and clinical application, making it essential reading for professionals and academicians committed to improving mental health outcomes. With a commitment to fostering scholarly discourse, the Brazilian Journal of Psychiatry not only enriches the academic landscape but also enhances the practice of psychiatry through its widespread accessibility and dedication to excellence in research.

ACTA NEUROPSYCHIATRICA is a distinguished journal published by Cambridge University Press, covering essential research across the fields of psychiatry and neuroscience. Since its inception in 1989, it has become a pivotal resource for researchers and clinicians, providing a platform for the latest advancements and insights in biological psychiatry. With an impressive Scopus rank of #66 out of 567 in the Psychiatry and Mental Health category, and #10 out of 51 in Biological Psychiatry, the journal is recognized for its significant contributions to the field, boasting an 88th percentile ranking in overall impact. Although it operates under a traditional access model, the journal remains committed to disseminating high-quality research that addresses critical issues in mental health. Whether you are a professional seeking the latest findings or a student aiming to deepen your knowledge, ACTA NEUROPSYCHIATRICA is an indispensable resource for cutting-edge developments that shape our understanding of the human mind.